Effect of a Nebulizer Holding Chamber on Aerosol Delivery

References

1. 1.↵
   1. Saeed H,
   2. Elberry AA,
   3. Eldin AS,
   4. Rabea H,
   5. Abdelrahim ME

   . Effect of nebulizer designs on aerosol delivery during non-invasive mechanical ventilation: a modeling study of in vitro data. Pulm Ther 2017;3(1):233–241.

   OpenUrl
2. 2.↵
   1. Ari A

   . Jet, ultrasonic, and mesh nebulizers: an evaluation of nebulizers for better clinical outcomes. Eurasian J Pulmonol 2014;16:1–7.

   OpenUrl
3. 3.↵
   1. Ari A,
   2. Restrepo RD

   . Aerosol delivery device selection for spontaneously breathing patients: 2012. Respir Care 2012;57(4):613–626.

   OpenUrlAbstract/FREE Full Text
4. 4.
   1. Dolovich MB,
   2. Dhand R

   . Aerosol drug delivery: developments in device design and clinical use. Lancet 2011;377(9770):1032–1045.

   OpenUrlCrossRefPubMed
5. 5.↵
   1. Dunne RB,
   2. Shortt S

   . Comparison of bronchodilator administration with vibrating mesh nebulizer and standard jet nebulizer in the emergency department. Am J Emerg Med 2017; pii: S0735-6757(17)30907–5.

   OpenUrl
6. 6.↵
   1. Lin HL,
   2. Cho HS,
   3. Wan GH,
   4. Hsieh MJ

   . Performance of different types of nebulizer with spontaneous adult breathing pattern. A50 asthma: observational studies. Am Thoracic Soc 2016;A1755.
7. 7.↵
   1. Madney YM,
   2. Fathy M,
   3. Elberry AA,
   4. Rabea H,
   5. Abdelrahim ME

   . Nebulizers and spacers for aerosol delivery through adult nasal cannula at low oxygen flow rate: An in-vitro study. J Drug Deliv Sci Technol 2017;39:260–265.

   OpenUrl
8. 8.↵
   1. Abdelrahim ME,
   2. Plant P,
   3. Chrystyn H

   . In-vitro characterisation of the nebulised dose during non-invasive ventilation. J Pharm Pharmacol 2010;62(8):966–972.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Hassan A,
   2. Rabea H,
   3. Hussein RR,
   4. Salah Eldin R,
   5. Abdelrahman MM,
   6. Said ASA,
   7. et al

   . In-vitro characterization of the aerosolized dose during non-invasive automatic continuous positive airway pressure ventilation. Pulm Ther 2016;2(1):115–126.

   OpenUrl
10. 10.↵
    1. Abdelrahim ME

    . Aerodynamic characteristics of nebulized terbutaline sulphate using the Andersen Cascade Impactor compared to the Next Generation Impactor. Pharm Dev Technol 2011;16(2):137–145.

    OpenUrlPubMed
11. 11.↵
    1. Hindle M,
    2. Chrystyn H

    . Determination of the relative bioavailability of salbutamol to the lung following inhalation. Br J Clin Pharmacol 1992;34(4):311–315.

    OpenUrlPubMedWeb of Science
12. 12.↵
    1. Silkstone VL,
    2. Dennis JH,
    3. Pieron CA,
    4. Chrystyn H

    . An investigation of in vitro/in vivo correlations for salbutamol nebulized by eight systems. J Aerosol Med 2002;15(3):251–259.

    OpenUrlPubMed
13. 13.↵
    1. Mazhar SH,
    2. Ismail NE,
    3. Newton DA,
    4. Chrystyn H

    . Relative lung deposition of salbutamol following inhalation from a spacer and a Sidestream jet nebulizer following an acute exacerbation. Br J Clin Pharmacol 2008;65(3):334–337.

    OpenUrlPubMed
14. 14.↵
    1. Hassan A,
    2. Salah Eldin R,
    3. Abdelrahman MM,
    4. Abdelrahim ME

    . In-vitro/in-vivo comparison of inhaled salbutamol dose delivered by jet nebulizer, vibrating mesh nebulizer and metered dose inhaler with spacer during non-invasive ventilation. Exp Lung Res 2017;43(1):19–28.

    OpenUrl
15. 15.↵
    1. Rabea H,
    2. Ali AM,
    3. Salah Eldin R,
    4. Abdelrahman MM,
    5. Said AS,
    6. Abdelrahim ME

    . Modelling of in-vitro and in-vivo performance of aerosol emitted from different vibrating mesh nebulisers in non-invasive ventilation circuit. Eur J Pharm Sci 2017;97:182–191.

    OpenUrl
16. 16.↵
    1. ElHansy MHE,
    2. Boules ME,
    3. El Essawy AFM,
    4. Al-Kholy MB,
    5. Abdelrahman MM,
    6. Said ASA,
    7. et al

    . Inhaled salbutamol dose delivered by jet nebulizer, vibrating mesh nebulizer and metered dose inhaler with spacer during invasive mechanical ventilation. Pulm Pharmacol Ther 2017;45:159–163.

    OpenUrl
17. 17.
    1. Moustafa IOF,
    2. Ali MRA,
    3. Al Hallag M,
    4. Rabea H,
    5. Fink JB,
    6. Dailey P,
    7. Abdelrahim MEA

    . Lung deposition and systemic bioavailability of different aerosol devices with and without humidification in mechanically ventilated patients. Heart Lung 2017;46(6):464–467.

    OpenUrl
18. 18.↵
    1. Hussein RRS,
    2. M A Ali A,
    3. Salem HF,
    4. Abdelrahman MM,
    5. Said ASA,
    6. Abdelrahim MEA

    . In vitro/in vivo correlation and modeling of emitted dose and lung deposition of inhaled salbutamol from metered dose inhalers with different types of spacers in noninvasively ventilated patients. Pharm Dev Technol 2017;22(7):871–880.

    OpenUrl
19. 19.↵
    1. Vecellio L,
    2. Abdelrahim ME,
    3. Montharu J,
    4. Galle J,
    5. Diot P,
    6. Dubus JC

    . Disposable versus reusable jet nebulizers for cystic fibrosis treatment with tobramycin. J Cyst Fibros 2011;10(2):86–92.

    OpenUrlCrossRefPubMed
20. 20.↵
    1. Abdelrahim ME,
    2. Plant PK,
    3. Chrystyn H

    . The relative lung and systemic bioavailability of terbutaline following nebulisation in non-invasively ventilated patients. Int J Pharm 2011;420(2):313–318.

    OpenUrlPubMed
21. 21.↵
    1. Abdelrahim ME,
    2. Chrystyn H

    . Aerodynamic characteristics of nebulized terbutaline sulphate using the Next Generation Impactor (NGI) and CEN method. J Aerosol Med Pulm Drug Deliv 2009;22(1):19–28.

    OpenUrlPubMed
22. 22.↵
    1. Saeed H,
    2. Mohsen M,
    3. Fink JB,
    4. Dailey P,
    5. Salah Eldin A,
    6. Abdelrahman MM,
    7. et al

    . Fill volume, humidification and heat effects on aerosol delivery and fugitive emissions during noninvasive ventilation. J Drug Deliv Sci Technol 2017;39:372–378.

    OpenUrl
23. 23.↵
    1. ElHansy MHE,
    2. Boules ME,
    3. Farid H,
    4. Chrystyn H,
    5. El-Maraghi SK,
    6. Al-Kholy MB,
    7. et al

    . In vitro aerodynamic characteristics of aerosol delivered from different inhalation methods in mechanical ventilation. Pharm Dev Technol 2017;22(6):844–849.

    OpenUrl
24. 24.↵
    1. Harb HS,
    2. Elberry AA,
    3. Rabea H,
    4. Fathy M,
    5. Abdelrahim ME

    . Is Combihaler usable for aerosol delivery in single limb non-invasive mechanical ventilation? J Drug Deliv Sci Technol 2017;40:28–34.

    OpenUrl
25. 25.↵
    1. Loborec SM,
    2. Johnson SE,
    3. Keating EA

    . Financial effect of converting ipratropium–albuterol therapy from inhalers to nebulizer treatments at an academic health system. Am J Health Syst Pharm 2016;73(3):121–125.

    OpenUrlAbstract/FREE Full Text
26. 26.↵
    1. Dugernier J,
    2. Hesse M,
    3. Vanbever R,
    4. Depoortere V,
    5. Roeseler J,
    6. Michotte JB,
    7. et al

    . SPECT-CT comparison of lung deposition using a system combining a vibrating-mesh nebulizer with a valved holding chamber and a conventional jet nebulizer: A randomized cross-over study. Pharm Res 2017;34(2):290–300.

    OpenUrl
27. 27.↵
    1. Schloss J,
    2. Mitchell JP

    . Evaluating upper and lower airway nebulizer-delivery of an inhaled reliever medication for bronchoconstrictive disease in the laboratory, simulating adult tidal breathing and using an anatomic oropharyngeal model. Respir Care 2016;61(10).
28. 28.↵
    1. Dunne R,
    2. Shortt S,
    3. Dailey P

    . 135 Aerosol dose matters in the emergency department: A comparison of the impact of bronchodilator administration with two nebulizer systems. Ann Emerg Med 2016;68(4):S54.

    OpenUrl
29. 29.↵
    1. Ari A,
    2. Fink JB,
    3. Pilbeam SP

    . Secondhand aerosol exposure during mechanical ventilation with and without expiratory filters: An in-vitro study. Indian J Respir Care 2016;5(1):1–6.

    OpenUrl